MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria [Hide filter]
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
Too much news? Try filtering with NewsWatch. Alternatively, try our Desktop News Alert.

The following articles are from the past month only. Click here for older news.
 
First     Previous     Next
01/06/23 08:07 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca discontinues brazikumab; Lynparza wins approval ALN
26/05/23 14:34 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s Ultomiris wins another approval in Japan ALN
26/05/23 08:14 Astrazeneca PLC (AZN) AstraZeneca’s Imfinzi plus Lynparza effective for endometrial cancer ALN
22/05/23 08:42 Astrazeneca PLC (AZN) IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director ALN
17/05/23 09:53 Astrazeneca PLC (AZN) AstraZeneca’s Tagrisso plus chemotherapy effective against lung cancer ALN
10/05/23 15:01 (AZN) Director Deals - (AZN) BFN
10/05/23 08:50 Astrazeneca PLC (AZN) AstraZeneca’s Ultomiris approved in EU for autoimmune disease NMOSD ALN
09/05/23 09:09 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s Farxiga approved in US to treat heart failure ALN
03/05/23 06:01 (AZN) Director Deals - (AZN) BFN
02/05/23 14:28 Astrazeneca PLC (AZN) IN BRIEF: AstraZeneca Chair Michel Demare buys £230,000 in shares ALN
02/05/23 09:06 Astrazeneca PLC (AZN) AstraZeneca bemoans ODAC judgement on use of Lynparza drug for cancer ALN
01/05/23 12:35 Astrazeneca PLC (AZN) AstraZeneca ‘disappointed’ with US ODAC’s guidance on Lynparza ALN
27/04/23 09:26 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca profit jumps despite Covid-19 sales decline ALN
17/04/23 06:45 Astrazeneca PLC (AZN) AstraZeneca reports positive results for lung cancer drug combination ALN
14/04/23 08:24 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern ALN
11/04/23 08:57 Astrazeneca PLC (AZN) TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal ALN
06/04/23 07:55 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s cancer drug Lynparza approved by NHS England ALN
05/04/23 09:13 Astrazeneca PLC (AZN) AstraZeneca receives positive interim trial results for Imfinzi drug ALN
03/04/23 08:45 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s ultomiris recommended for EU approval ALN
30/03/23 09:27 Astrazeneca PLC (AZN) AstraZeneca signs exclusive global license deal with KYM Biosciences ALN
28/03/23 06:02 (AZN) Director Deals - (AZN) BFN
27/03/23 08:52 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca hails eplontersen; Enhertu wins another approval ALN
23/03/23 08:58 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s Calquence receives first approval in China ALN
09/03/23 10:34 Astrazeneca PLC (AZN) AstraZeneca hails trial results of cancer drugs Imfinzi and Tagrisso ALN
09/03/23 06:02 (AZN) Director Deals - (AZN) BFN
09/03/23 06:02 (AZN) Director Deals - (AZN) BFN
06/03/23 08:29 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca hails Enhertu phase 2 trial results ALN
02/03/23 17:20 Astrazeneca PLC (AZN) US FDA to discuss AstraZeneca and Merck’s Lynparza cancer drug combo ALN
01/03/23 19:38 Astrazeneca PLC (AZN) IN BRIEF: AstraZeneca prices three tranche global bond offering ALN
24/02/23 14:35 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca closes CinCor buy; Enhertu wins Chinese approval ALN
23/02/23 09:01 Astrazeneca PLC (AZN) AstraZeneca signs $63 million agreement to address gastric cancer ALN
22/02/23 09:11 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca wins three approvals in EU for cancer drugs ALN
21/02/23 09:42 Astrazeneca PLC (AZN) AstraZeneca reports protection against RSV in infants with Beyfortus ALN
15/02/23 14:30 Astrazeneca PLC (AZN) AstraZeneca’s Evusheld not recommended by NHS for vulnerable people ALN
14/02/23 06:01 (AZN) Director Deals - (AZN) BFN
14/02/23 06:01 (AZN) Director Deals - (AZN) BFN
14/02/23 06:01 (AZN) Director Deals - (AZN) BFN
10/02/23 10:32 Astrazeneca PLC (AZN) UPDATE: Hunt disappointed UK loses new AstraZeneca factory to Ireland ALN
10/02/23 10:27 Astrazeneca PLC (AZN) Hunt disappointed UK ’lost out this time’ on new AstraZeneca factory ALN
09/02/23 08:42 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca swings to profit as Alexion adds to 2022 revenue ALN
07/02/23 08:23 Astrazeneca PLC (AZN) CORRECT: EU approves AstraZeneca’s Forxiga for chronic heart failure ALN
07/02/23 08:05 Astrazeneca PLC (AZN) TOP NEWS: EU approves AstraZeneca’s Forxiga for chronic heart failure ALN
30/01/23 16:35 Astrazeneca PLC (AZN) Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment ALN
26/01/23 09:40 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s Enhertu approved in EU for breast cancer form ALN
16/01/23 08:49 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca completes acquisition of Neogene Therapeutics ALN
13/01/23 09:08 Astrazeneca PLC (AZN) CORRECT: AstraZeneca asthma drug okayed in EU for self-administration ALN
13/01/23 08:29 Astrazeneca PLC (AZN) AstraZeneca asthma drug approved in US for self-administration ALN
11/01/23 14:05 Astrazeneca PLC (AZN) TOP NEWS: FDA approves AstraZeneca asthma drug Airsupra for adults ALN
09/01/23 09:11 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca buys biotech CinCor for up to $1.8 billion ALN
05/01/23 07:47 Astrazeneca PLC (AZN) TOP NEWS: AstraZeneca’s and Sanofi’s nirsevimab approved for US review ALN
First     Previous     Next